Rituximab (MabThera®) for the treatment of paediatric patients with previously untreated advanced stage CD20 positive DLBCL, BL, BAL, or BLL

Grössmann, N. (2020): Rituximab (MabThera®) for the treatment of paediatric patients with previously untreated advanced stage CD20 positive DLBCL, BL, BAL, or BLL. Oncology Fact Sheet Nr. 3.

[thumbnail of Oncology_Fact_Sheet_Nr.3.pdf]

Preview

PDF - Sie müssen einen PDF-Viewer auf Ihrem PC installiert haben wie z. B. GSview, Xpdf oder Adobe Acrobat Reader
40kB

Item Type:	Horizon Scanning of Medicines
Subjects:	WB Practice of medicine > WB 300-962 Therapeutics WS Pediatrics WH Hemic and lymphatic systems QZ Pathology > QZ 200-380 Neoplasms.Cysts QV Pharmacology, toxicology, pharmacy > QV 60-370 Pharmacology
Language:	English
Series Name:	Oncology Fact Sheet Nr. 3
Deposited on:	01 Apr 2020 09:59
Last Modified:	10 Jul 2025 11:29

Repository Staff Only: item control page